PF-Atlas › Clinical Trials › NCT00351078
PTC124 for the Treatment of Cystic Fibrosis
PTC124 · Phase 2
Registry ID
NCT00351078
Phase
Phase 2
Status
Completed
Drug / intervention
PTC124
Sponsor
PTC Therapeutics
Start
2006-12
About this trial
PTC124 is evaluated in NCT00351078, a Phase 2 idiopathic pulmonary fibrosis study sponsored by PTC Therapeutics. Current status: Completed.
Explore related
Medical disclaimer. This page summarizes public trial data for NCT00351078 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.